
Progressive Corporation (PGR) is projected to report strong second-quarter 2025 results on July 16, with consensus estimates anticipating revenues of $21.5 billion, a 17.9% year-over-year increase, and earnings per share of $4.30, representing a 62.3% surge. The EPS estimate has seen a 9.4% upward revision in the past 30 days, driven by expectations of higher premiums, increased net investment income, and fewer catastrophic events. The Zacks model further predicts an earnings beat for PGR, supported by a positive Earnings ESP and a favorable Zacks Rank, building on its history of exceeding estimates in three of the last four quarters.
The Progressive Corporation (PGR) is positioned for a robust second-quarter 2025 financial report, with consensus estimates pointing to significant year-over-year growth. Revenue is projected to reach $21.5 billion, a 17.9% increase, while earnings per share are forecasted to surge by 62.3% to $4.30. Analyst sentiment has strengthened leading up to the release, evidenced by a 9.4% upward revision of the EPS consensus estimate in the past 30 days. This bullish outlook is underpinned by several fundamental drivers, including strong growth in net premiums earned (consensus $20.2 billion) fueled by solid policy retention and market leadership in its Vehicle and Property businesses. Furthermore, profitability is expected to be enhanced by a relatively benign quarter for catastrophic events and prudent underwriting, which is anticipated to yield a favorable combined ratio of 89. Higher net investment income, with a consensus of $861 million, is also set to bolster the bottom line. The quantitative Zacks model reinforces this positive outlook, predicting an earnings beat based on a positive Earnings ESP of +2.41%, which indicates the most accurate estimate ($4.41) is above the consensus, and a favorable Zacks Rank.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment